World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
39054
World Ranking
7065
National Ranking
3714

Robert S. Negrin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Robert S. Negrin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 591 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Robert S. Negrin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Robert S. Negrin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Robert S. Negrin is affiliated with Stanford University in the United States. Their research focuses primarily on medicine and immunology and microbiology, with subfields including immunology, oncology, hematology, molecular biology, and genetics.

The scientist's work extensively covers topics related to CAR-T cell therapy research, immune cell function and interaction, hematopoietic stem cell transplantation, T-cell and B-cell immunology, multiple myeloma research and treatments, chronic myeloid leukemia treatments, and acute myeloid leukemia research.

Frequent co-authors in their research include:

  • Everett Meyer
  • Lori Muffly
  • Parveen Shiraz
  • Andrew R. Rezvani
  • Sally Arai

Robert S. Negrin has published numerous papers, notably in the following venues:

  • Blood
  • Transplantation and Cellular Therapy
  • Blood Advances
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Lymphoma Myeloma & Leukemia

Some of their recent publications include:

  • CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial, 2021, Nature Medicine
  • Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma, 2021, Blood Advances
  • Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET, 2020, Clinical Cancer Research
  • MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors, 2020, JCI Insight
  • CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphoma, 2020, Blood

Robert S. Negrin is a member of the Association of American Physicians, an award recognizing a professional standing within the medical research community.

Best Publications

  • CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.

    Matthias Edinger;Matthias Edinger;Petra Hoffmann;Petra Hoffmann;Joerg Ermann;Kathryn Drago

  • Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.

    Loredana Ruggeri;Marusca Capanni;Marusca Capanni;Myriam Casucci;Myriam Casucci;Isabella Volpi;Isabella Volpi

  • Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

    William I. Bensinger;Paul J. Martin;Barry Storer;Reginald Clift

  • Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.

    Ingo G H Schmidt-Wolf;Robert S. Negrin;Hans Peter Kiem;Karl G. Blume

  • A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.

    Pei-Hua Lu;R. S. Negrin

  • Thomas' hematopoietic cell transplantation

    Frederick R. Appelbaum;Stephen J. Forman;Robert S. Negrin;Karl G. Blume

  • Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

    R. Zeiser;A. Burchert;C. Lengerke;M.M. Verbeek

  • Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production

    Robert S Zeiser;Vu H Nguyen;Andreas Beilhack;Martin Buess

  • Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD

    Joerg Ermann;Petra Hoffmann;Petra Hoffmann;Petra Hoffmann;Matthias Edinger;Matthias Edinger;Matthias Edinger;Suparna Dutt;Suparna Dutt;Suparna Dutt

  • Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma

    Susan J. Knox;Michael L. Goris;Kirk Trisler;Robert Negrin

  • Use of reporter genes for optical measurements of neoplastic disease in vivo.

    Christopher H. Contag;Darlene Jenkins;Pamela R. Contag;Robert S. Negrin

  • American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.

    Martee L. Hensley;Lynn M. Schuchter;Celeste Lindley;Neal J. Meropol

  • Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells.

    Michael R. Verneris;Michael R. Verneris;Mobin Karami;Mobin Karami;Jeanette Baker;Jeanette Baker;Anishka Jayaswal;Anishka Jayaswal

  • Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system.

    Judith A. Shizuru;Robert S. Negrin;Irving L. Weissman

  • High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices.

    Sandra J. Horning;Nelson J. Chao;Robert S. Negrin;Richard T. Hoppe

  • Visualizing the kinetics of tumor-cell clearance in living animals

    Thomas J. Sweeney;Volker Mailänder;Amanda A. Tucker;Adesuwa B. Olomu

  • Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.

    I. G. H. Schmidt-Wolf;P. Lefterova;B. A. Mehta;L. P. Fernandez

  • Protective conditioning for acute graft-versus-host disease.

    Robert Lowsky;Tsuyoshi Takahashi;Yin Ping Liu;Sussan Dejbakhsh-Jones

  • Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging

    Matthias Edinger;Yu An Cao;Michael R. Verneris;Michael H. Bachmann

  • In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets

    Andreas Beilhack;Stephan Schulz;Jeanette Baker;Georg F. Beilhack

Frequent Co-Authors

Judith A. Shizuru
Judith A. Shizuru Stanford University
Robert Zeiser
Robert Zeiser University of Freiburg
Christopher H. Contag
Christopher H. Contag Michigan State University
Karl G. Blume
Karl G. Blume Stanford University
Samuel Strober
Samuel Strober Stanford University
Nelson J. Chao
Nelson J. Chao Duke University
Peter L. Greenberg
Peter L. Greenberg Stanford University
Michael R. Verneris
Michael R. Verneris University of Colorado Denver
Matthias Edinger
Matthias Edinger University of Regensburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in studying Medicine in the USA, a variety of related online degrees and career pathways are available. These programs offer flexibility for students balancing work, family, or other commitments. Online healthcare degrees can prepare you for rewarding roles ranging from nursing to advanced practice.

One popular option is pursuing an affordable online fnp programs, which allow registered nurses to become Family Nurse Practitioners and provide primary care in a variety of settings. Additionally, you can explore an nursing degree online that offers foundational knowledge for a successful nursing career.

For those seeking leadership or academic roles, consider doctorate in nursing education online programs, which enable nurses to advance their expertise and contribute to the future of nursing through research and teaching.

If you are already an RN and want to take your career to the next level, explore the cheapest online bsn programs. These bridge programs let you earn a Bachelor of Science in Nursing on a flexible schedule.

Best Scientists Citing Robert S. Negrin

Trending Scientists

Recently Published Articles